| P50 | author | Elda Righi | Q79385925 |
| | Matteo Bassetti | Q88607142 |
| P2093 | author name string | Alessia Carnelutti | |
| P2860 | cites work | Attributable Morbidity and Mortality of Catheter-Related Septicemia in Critically Ill Patients: a Matched, Risk-Adjusted, Cohort Study | Q58416360 |
| | Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy | Q64131374 |
| | Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia | Q64131379 |
| | Piperacillin-tazobactam for Pseudomonas aeruginosa infection: clinical implications of an extended-infusion dosing strategy | Q79497432 |
| | Health-care-associated bloodstream infections at admission to the ICU | Q82600486 |
| | Daptomycin versus vancomycin for bloodstream infections due to methicillin-resistant Staphylococcus aureus with a high vancomycin minimum inhibitory concentration: a case-control study | Q82644438 |
| | Excess risk of death from intensive care unit-acquired nosocomial bloodstream infections: a reappraisal | Q83022635 |
| | Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock | Q83177700 |
| | Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment | Q84148237 |
| | Reduction of catheter-related bloodstream infections through the use of a central venous line bundle: epidemiologic and economic consequences | Q84274028 |
| | Antibiotic treatment duration for bloodstream infections in critically ill patients: a national survey of Canadian infectious diseases and critical care specialists | Q85064029 |
| | Early use of daptomycin versus vancomycin for methicillin-resistant Staphylococcus aureus bacteremia with vancomycin minimum inhibitory concentration >1 mg/L: a matched cohort study | Q86222628 |
| | Catheter-related bloodstream infections | Q93609428 |
| | Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis | Q24201201 |
| | Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality | Q24530412 |
| | Population-based epidemiology and microbiology of community-onset bloodstream infections | Q27013639 |
| | Procalcitonin-guided therapy in intensive care unit patients with severe sepsis and septic shock--a systematic review and meta-analysis | Q27028085 |
| | Mortality and hospital stay associated with resistant Staphylococcus aureus and Escherichia coli bacteremia: estimating the burden of antibiotic resistance in Europe | Q28477449 |
| | Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012 | Q29615429 |
| | Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study | Q29616607 |
| | Abdominal infections in the intensive care unit: characteristics, treatment and determinants of outcome | Q30411367 |
| | Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group | Q31797996 |
| | Carbapenemase-producing Klebsiella pneumoniae bloodstream infections: lowering mortality by antibiotic combination schemes and the role of carbapenems | Q33623060 |
| | Predictive models for identification of hospitalized patients harboring KPC-producing Klebsiella pneumoniae | Q33798081 |
| | Revisiting the loading dose of amikacin for patients with severe sepsis and septic shock | Q33919190 |
| | In vitro activities of daptomycin against 2,789 clinical isolates from 11 North American medical centers | Q33982424 |
| | Influence of empiric therapy with a beta-lactam alone or combined with an aminoglycoside on prognosis of bacteremia due to gram-negative microorganisms. | Q34108527 |
| | Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary | Q34158152 |
| | Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention | Q34190800 |
| | The distinct category of healthcare associated bloodstream infections | Q34225748 |
| | Duration of antibiotic therapy for bacteremia: a systematic review and meta-analysis | Q34232870 |
| | Policy statement on antimicrobial stewardship by the Society for Healthcare Epidemiology of America (SHEA), the Infectious Diseases Society of America (IDSA), and the Pediatric Infectious Diseases Society (PIDS). | Q34261329 |
| | Cost-effectiveness of a quality improvement programme to reduce central line-associated bloodstream infections in intensive care units in the USA. | Q34264272 |
| | Multidrug-resistant Pseudomonas aeruginosa: risk factors and clinical impact. | Q34301559 |
| | Multistate point-prevalence survey of health care-associated infections | Q34412128 |
| | Empirical antifungal therapy with an echinocandin in critically-ill patients: prospective evaluation of a pragmatic Candida score-based strategy in one medical ICU | Q34487220 |
| | Multi-drug resistance, inappropriate initial antibiotic therapy and mortality in Gram-negative severe sepsis and septic shock: a retrospective cohort study | Q34686057 |
| | Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients | Q34991274 |
| | Acquired bloodstream infection in the intensive care unit: incidence and attributable mortality. | Q35559502 |
| | Prevalence of Klebsiella pneumoniae strains producing carbapenemases and increase of resistance to colistin in an Italian teaching hospital from January 2012 To December 2014 | Q35676151 |
| | Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment | Q35840852 |
| | Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: superiority of combination antimicrobial regimens | Q35867414 |
| | The epidemiology and control of Acinetobacter baumannii in health care facilities | Q36382140 |
| | Emergence of imipenem-resistant gram-negative bacilli in intestinal flora of intensive care patients | Q36667172 |
| | Procalcitonin levels in surgical patients at risk of candidemia | Q45089666 |
| | Infections caused by carbapenem-resistant Klebsiella pneumoniae among patients in intensive care units in Greece: a multi-centre study on clinical outcome and therapeutic options | Q45836707 |
| | Catheter application, insertion vein and length of ICU stay prior to insertion affect the risk of catheter-related bloodstream infection. | Q45901467 |
| | Safety and clinical outcomes when utilizing high-dose (> or =8 mg/kg) daptomycin therapy. | Q45936598 |
| | Outcomes of extended infusion piperacillin/tazobactam for documented Gram-negative infections. | Q45981027 |
| | Carbapenem resistance among Klebsiella pneumoniae isolates: risk factors, molecular characteristics, and susceptibility patterns. | Q45982863 |
| | Clinical cure of ventilator-associated pneumonia treated with piperacillin/tazobactam administered by continuous or intermittent infusion | Q46159338 |
| | Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008-2009). | Q46306343 |
| | Resistance to empiric antimicrobial treatment predicts outcome in severe sepsis associated with Gram-negative bacteremia | Q46552287 |
| | De-escalation of antimicrobial treatment in neutropenic patients with severe sepsis: results from an observational study. | Q46744719 |
| | Meropenem by continuous versus intermittent infusion in ventilator-associated pneumonia due to gram-negative bacilli | Q46921577 |
| | Candida bloodstream infections in intensive care units: analysis of the extended prevalence of infection in intensive care unit study | Q47583016 |
| | ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. | Q47643534 |
| | Antibiotic use and impact on outcome from bacteraemic critical illness: the BActeraemia Study in Intensive Care (BASIC). | Q50143525 |
| | Acquisition of carbapenem-resistant Gram-negative bacilli in intensive care unit: predictors and molecular epidemiology. | Q51012738 |
| | Usefulness of the "Candida score" for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: a prospective multicenter study. | Q51181941 |
| | Secular trends in nosocomial bloodstream infections: antibiotic-resistant bacteria increase the total burden of infection. | Q51200476 |
| | Characteristics and determinants of outcome of hospital-acquired bloodstream infections in intensive care units: the EUROBACT International Cohort Study. | Q53123244 |
| | Population-based assessment of intensive care unit-acquired bloodstream infections in adults: Incidence, risk factors, and associated mortality rate. | Q53949896 |
| | Vancomycin MIC creep in MRSA blood culture isolates from Germany: a regional problem? | Q54392892 |
| | Community-acquired bloodstream infection in critically ill adult patients: impact of shock and inappropriate antibiotic therapy on survival. | Q54525540 |
| | Is empiric daptomycin effective in reducing mortality in Staphylococcus aureus bacteraemia? A real-life experience. | Q54785836 |
| | DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current -Lactam Antibiotic Doses Sufficient for Critically Ill Patients? | Q57237700 |
| | A survey on infection management practices in Italian ICUs | Q36902763 |
| | Antibiotic prescription patterns in the empiric therapy of severe sepsis: combination of antimicrobials with different mechanisms of action reduces mortality | Q36902771 |
| | Short antibiotic treatment courses or how short is short? | Q36934266 |
| | Extended-infusion cefepime reduces mortality in patients with Pseudomonas aeruginosa infections | Q36969880 |
| | A combined pharmacodynamic quantitative and qualitative model reveals the potent activity of daptomycin and delafloxacin against Staphylococcus aureus biofilms. | Q37026608 |
| | The increased risks of death and extra lengths of hospital and ICU stay from hospital-acquired bloodstream infections: a case-control study | Q37275812 |
| | Epidemiology, species distribution, antifungal susceptibility, and outcome of candidemia across five sites in Italy and Spain | Q37336194 |
| | Safety of high-dose intravenous daptomycin treatment: three-year cumulative experience in a clinical program | Q37509110 |
| | Early combination antibiotic therapy yields improved survival compared with monotherapy in septic shock: a propensity-matched analysis | Q37773767 |
| | High-dose daptomycin in documented Staphylococcus aureus infections | Q37789511 |
| | Antibiotic de-escalation | Q37818805 |
| | Management of ventilator-associated pneumonia: epidemiology, diagnosis and antimicrobial therapy. | Q38018983 |
| | Clinical outcomes with extended or continuous versus short-term intravenous infusion of carbapenems and piperacillin/tazobactam: a systematic review and meta-analysis | Q38052888 |
| | ESCMID* guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures. | Q38058556 |
| | Short-course therapy for severe infections. | Q38109291 |
| | Clinical implications of antibiotic pharmacokinetic principles in the critically ill. | Q38138835 |
| | Bacteremia and ventilator-associated pneumonia: a marker for contemporaneous extra-pulmonic infection | Q38160103 |
| | Arterial catheters as a source of bloodstream infection: a systematic review and meta-analysis. | Q38177636 |
| | Colistin resistance in Klebsiella pneumoniae | Q38209244 |
| | Fecal colonization and infection with Pseudomonas aeruginosa in recipients of allogeneic hematopoietic stem cell transplantation | Q38302802 |
| | β-lactam and β-lactamase inhibitor combinations in the treatment of extended-spectrum β-lactamase producing Enterobacteriaceae: time for a reappraisal in the era of few antibiotic options? | Q38365280 |
| | Preventive and therapeutic strategies in critically ill patients with highly resistant bacteria | Q38384662 |
| | Severe bloodstream infections: a population-based assessment | Q39681186 |
| | Success of an infection control program to reduce the spread of carbapenem-resistant Klebsiella pneumoniae | Q39878469 |
| | Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study | Q41299450 |
| | Impact of antibiotic exposure on occurrence of nosocomial carbapenem-resistant Acinetobacter baumannii infection: a case control study | Q41630965 |
| | Bloodstream infections in ICU with increased resistance: epidemiology and outcomes. | Q41739807 |
| | Bacteraemia incidence, causative organisms and resistance patterns, antibiotic strategies and outcomes in a single university hospital ICU: continuing improvement between 2000 and 2013. | Q41752757 |
| | Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: a prospective observational multicentre study. | Q42208163 |
| | A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality. | Q42216247 |
| | Potential role of active surveillance in the control of a hospital-wide outbreak of carbapenem-resistant Klebsiella pneumoniae infection | Q43108529 |
| | SDD and colistin resistance: end of a dream? | Q43699640 |
| | Risk factors associated with the onset of daptomycin non-susceptibility in Staphylococcus aureus infections in critically ill patients. | Q43949662 |
| | De-escalation versus continuation of empirical antimicrobial treatment in severe sepsis: a multicenter non-blinded randomized noninferiority trial | Q44019769 |
| | Intensive care unit-acquired blood stream infections: a 5-year retrospective analysis of a single tertiary care hospital in Korea | Q44044610 |
| | Does combination antimicrobial therapy reduce mortality in Gram-negative bacteraemia? A meta-analysis | Q44116286 |
| | De-escalation of empirical therapy is associated with lower mortality in patients with severe sepsis and septic shock. | Q44692768 |
| | Daptomycin activity and spectrum: a worldwide sample of 6737 clinical Gram-positive organisms | Q44777352 |
| | Continuous infusion of beta-lactam antibiotics in severe sepsis: a multicenter double-blind, randomized controlled trial | Q44830332 |
| | Cost of intensive care unit-acquired bloodstream infections | Q44837892 |
| | Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock. | Q44877949 |
| | Evaluation of vancomycin and daptomycin MIC trends for methicillin-resistant Staphylococcus aureus blood isolates over an 11 year period | Q44979977 |
| | International study of the prevalence and outcomes of infection in intensive care units | Q44988294 |
| | Carbapenem-resistant Acinetobacter baumannii in intensive care unit patients: risk factors for acquisition, infection and their consequences | Q45048702 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 267-279 | |
| P577 | publication date | 2016-01-13 | |
| P1433 | published in | Virulence | Q18712614 |
| P1476 | title | Bloodstream infections in the Intensive Care Unit | |
| P478 | volume | 7 | |